We are submitting herewith the intimation of closure of trading window

Kilitch Drugs (India) Ltd. KI 28" September, 2026 To, To, The Manager - Corporate Relationship The Manager - Corporate Compliance Dept. National Stock Exchange of India Ltd BSE Limited Exchange Plaza, Plot No.C-1, P. J. Towers, Dalal Street G Block, BKC, Bandra (E), Fort, Mumbai - 400 001 Mumbai 400 051 Scrip Code: BSE - 524500 Scrip Code: NSE - KILITCH Sub: Intimation of closure of Trading Window Dear Sir, Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time read with Code of Prohibition of Insider Trading of the Company, the Trading Windows for dealing in Securities of the Company will remain closed for designated persons of the Company and their immediate relatives with effect from Thursday, 1*' October, 2026 till the expiry of 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter ended 30 September, 2026. The date of the meeting of Board of Director to approve the Unaudited Financial Results of the Company for the quarter ended 30" September, 2026 will be intimated in due course. We request you to kindly take the same on record and acknowledge the receipt. Thanking you, For Kilitch Drugs (India) Limited Mukund Mehta Managing Director eIseo Nera ea 139408051::22000038 WHO CERTIFIED a eR ono. Corporate office : 37/39, Ujagar Industrial Estate, W. T. Patil Marg, Deonar, Mumbai - 400 088. e Tel.: +91-22-6121 4100 « Fax : +91-22-6703 1658 Registered Office & Manufacturing unit : C-301/2, M.1.D.C., T.T.C. Industrial Area, Pawane Village, Navi Mumbai - 400 705. Maharashtra. « GIN: L24239MH1992PLC066718 « Tel.; +91-22-6299 6300 « Fax : +91-22-2768 0912 « E-mail : info@kilitch.com « Website : www.kilitch.com